CY1107745T1 - Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια - Google Patents

Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια

Info

Publication number
CY1107745T1
CY1107745T1 CY20071101241T CY071101241T CY1107745T1 CY 1107745 T1 CY1107745 T1 CY 1107745T1 CY 20071101241 T CY20071101241 T CY 20071101241T CY 071101241 T CY071101241 T CY 071101241T CY 1107745 T1 CY1107745 T1 CY 1107745T1
Authority
CY
Cyprus
Prior art keywords
diabetes
thiazolidinodion
sulfonyluria
treatment
secretin
Prior art date
Application number
CY20071101241T
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1107745(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CY1107745T1 publication Critical patent/CY1107745T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Μέθοδος για την αγωγή του σακχαροδιαβήτη και καταστάσεων σχετιζόμενων με το σακχαροδιαβήτη σε ένα θηλαστικό, η οποία μέθοδος περιλαμβάνει τη χορήγηση μίας αποτελεσματικής μη τοξικής φαρμακευτικά αποδεκτής ποσότητος ενός ευαισθητοποιητή της ινσουλίνης και μίας μικρότερης από τη μέγιστη ποσότητας ενός εκκριταγωγού της ινσουλίνης, σε ένα θηλαστικό το οποίο την έχει ανάγκη και μία φαρμακευτική σύνθεση για χρήση σε μία τέτοια μέθοδο.
CY20071101241T 1997-07-18 2007-09-27 Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια CY1107745T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
EP98935126A EP0998291B2 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (1)

Publication Number Publication Date
CY1107745T1 true CY1107745T1 (el) 2013-04-18

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101241T CY1107745T1 (el) 1997-07-18 2007-09-27 Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια

Country Status (41)

Country Link
EP (1) EP0998291B2 (el)
JP (2) JP2001510158A (el)
KR (1) KR100680667B1 (el)
CN (1) CN1264302A (el)
AP (1) AP1318A (el)
AR (2) AR016768A1 (el)
AT (1) ATE366577T1 (el)
AU (1) AU743269B2 (el)
BG (1) BG64892B1 (el)
BR (1) BR9810904A (el)
CA (1) CA2297115C (el)
CO (1) CO4940422A1 (el)
CY (1) CY1107745T1 (el)
CZ (1) CZ302668B6 (el)
DE (1) DE69838066T3 (el)
DK (1) DK0998291T4 (el)
DZ (1) DZ2564A1 (el)
EA (1) EA003303B1 (el)
ES (1) ES2290989T5 (el)
GB (1) GB9715306D0 (el)
HK (1) HK1029272A1 (el)
HU (1) HU229119B1 (el)
ID (1) ID24198A (el)
IL (1) IL134045A0 (el)
IN (1) IN189035B (el)
MA (1) MA26522A1 (el)
MY (1) MY138246A (el)
NO (1) NO326356B1 (el)
NZ (3) NZ520652A (el)
OA (1) OA11632A (el)
PE (1) PE99799A1 (el)
PL (2) PL199125B1 (el)
PT (1) PT998291E (el)
SI (1) SI0998291T2 (el)
SK (2) SK287823B6 (el)
TR (1) TR200000135T2 (el)
TW (1) TW586926B (el)
UA (1) UA70302C2 (el)
UY (1) UY25103A1 (el)
WO (1) WO1999003476A1 (el)
ZA (1) ZA986365B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
MXPA03006217A (es) 2001-01-12 2004-10-15 Sun Pharmaceutical Ind Ltd Sistema de administracion espaciada de farmacos.
BRPI0414979A (pt) * 2003-10-31 2006-11-21 Takeda Pharmaceutical preparação sólida
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
PE20110019A1 (es) 2005-12-22 2011-01-27 Takeda Pharmaceutical Composicion farmaceutica que contiene un sensibilizante de insulina y un secretagogo de insulina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
AP1318A (en) 2004-10-22
BG104139A (en) 2000-11-30
ES2290989T3 (es) 2008-02-16
NO20000229L (no) 2000-01-17
SI0998291T1 (sl) 2007-12-31
TW586926B (en) 2004-05-11
IL134045A0 (en) 2001-04-30
PE99799A1 (es) 1999-12-22
EP0998291A1 (en) 2000-05-10
OA11632A (en) 2004-11-22
MA26522A1 (fr) 2004-12-20
UA70302C2 (uk) 2004-10-15
DZ2564A1 (fr) 2003-02-15
CN1264302A (zh) 2000-08-23
NO20000229D0 (no) 2000-01-17
ID24198A (id) 2000-07-13
PL338127A1 (en) 2000-09-25
DK0998291T4 (da) 2011-09-26
CA2297115A1 (en) 1999-01-28
WO1999003476A1 (en) 1999-01-28
AR019331A2 (es) 2002-02-13
EP0998291B1 (en) 2007-07-11
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
ES2290989T5 (es) 2011-11-11
DK0998291T3 (da) 2007-11-05
CO4940422A1 (es) 2000-07-24
PL199125B1 (pl) 2008-08-29
GB9715306D0 (en) 1997-09-24
EP0998291B2 (en) 2011-07-06
EA200000141A1 (ru) 2000-08-28
AR016768A1 (es) 2001-08-01
SK288053B6 (sk) 2013-03-01
TR200000135T2 (tr) 2000-05-22
KR100680667B1 (ko) 2007-02-09
DE69838066T3 (de) 2012-03-29
HU229119B1 (en) 2013-08-28
IN189035B (el) 2002-12-07
PT998291E (pt) 2007-10-11
JP2005247865A (ja) 2005-09-15
UY25103A1 (es) 2000-12-29
MY138246A (en) 2009-05-29
ZA986365B (en) 2000-01-17
BG64892B1 (bg) 2006-08-31
NO326356B1 (no) 2008-11-17
ATE366577T1 (de) 2007-08-15
JP2001510158A (ja) 2001-07-31
SI0998291T2 (sl) 2011-10-28
NZ520652A (en) 2004-06-25
CA2297115C (en) 2010-02-23
CZ2000173A3 (en) 2001-05-16
AU8448798A (en) 1999-02-10
AP2000001734A0 (en) 2000-03-31
DE69838066D1 (de) 2007-08-23
AU743269B2 (en) 2002-01-24
HK1029272A1 (en) 2001-03-30
SK602000A3 (en) 2000-07-11
HUP0003634A2 (hu) 2001-07-30
BR9810904A (pt) 2000-09-26
KR20010021948A (ko) 2001-03-15
SK287823B6 (sk) 2011-11-04
CZ302668B6 (cs) 2011-08-24
NZ515555A (en) 2002-09-27
HUP0003634A3 (en) 2003-04-28
NZ501256A (en) 2002-09-27

Similar Documents

Publication Publication Date Title
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
CY1107643T1 (el) Αντιμετωπιση του διαβητη με θειαζολιδινοδιονη και μετφορμινη
CY1105254T1 (el) Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο
CY1119109T1 (el) Συσκευη που μπορει να εμφυτευθει που περιεχει υλικο μητρας που μπορει να απορροφηθει και ραπαμυκινη για την προληψη ή την θεραπεια αγγειο-πολλαπλασιαστικων ασθενειων
NO976063L (no) Fremgangsmåte for behandling av diabetes
ES2059121T5 (es) Uso de agentes sensibilizantes de la insulina para tratar la hipertension.
TR200101174T2 (tr) Migren tedavisi için 5HT1, reseptör agonistleri ve metoklopramid.
ATE231725T1 (de) Pharmazeutische zubereitungen zur oralen verabreichung von molekulares jod
ITBO950533A0 (it) Siringa per iniezioni ipodermiche.
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
AR019724A2 (es) Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
NO996270L (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
DK1156795T3 (da) Anvendelse af ravsyre eller salte deraf, og fremgangsmåde til behandling af insulinresistens
CO5170459A1 (es) Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos
EA200100539A1 (ru) Новый способ лечения
CY1105657T1 (el) Θεραπεια ηπατιτιδας c με θυμοσινη και σταθεροποιημενη ιντερφερονη
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
EA200000419A1 (ru) Применение тиазолидиндионов для лечения гипергликемии
ECSP982593A (es) Nuevo metodo de tratamiento vi
EA200300222A1 (ru) Лечение гепатита c с помощью тимозина, интерферона и рибавирина
PT1171160E (pt) Metodo e meios para tratar o sindroma pos poliomielite
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами